The market for weight loss injections: Fat profits through weight loss supplements
capital.de/geld-versicherungen/pharma-aktien--fette-gewinne-fuer-eine-schlanke-zukunft-34441842.html
Story Details
| Last Updated | Feb 11 |
| Total Articles | 1 |
More articles on this subject
Previous
US Senate committee investigates pricing of Novo's Ozempic and Wegovy: A U.S. Senate committee said on Wednesday it had launched an investigation into the prices ...
reuters.com/business/healthcare-pharmaceuticals/us-senate-committee-investigates-pricing-novos-ozempic-wegovy-2024-04-24/
Baron Health Care Fund Q1 2024 Shareholder Letter: In the quarter ended March 31, 2024, Baron Health Care Fund advanced 8.92% compared with the 8 ...
seekingalpha.com/article/4685283-baron-health-care-fund-q1-2024-shareholder-letter
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy: Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss ...
nytimes.com/2024/04/20/business/ozempic-novo-nordisk-wegovy.html
German watchdog approves Novo's acquisition of Cardior Pharmaceuticals: The German cartel office has approved a deal by Denmark's Novo Nordisk to purchase ...
reuters.com/business/healthcare-pharmaceuticals/german-watchdog-approves-novos-acquisition-cardior-pharmaceuticals-2024-04-18/
Plaintiffs' lawyers chosen to lead Ozempic litigation: A federal judge has appointed eight plaintiffs' lawyers to leadership roles in federal mass tort ...
reuters.com/legal/litigation/plaintiffs-lawyers-chosen-lead-ozempic-litigation-2024-04-24/
India's Biocon developing its own version of Wegovy, clinical trial likely next year
reuters.com/business/healthcare-pharmaceuticals/indias-biocon-developing-its-own-version-wegovy-clinical-trial-likely-next-year-2024-04-18/
Quick Glance: Biocon Developing Own Version of Wegovy, Plans Clinical Trial
- Indian pharmaceutical company Biocon is working on developing its own version of Novo Nordisk's popular Wegovy and is likely to conduct a clinical trial next year to enter the growing weight-loss drug market.
- Biocon's CEO, Siddharth Mittal, has expressed the company's intention to develop semaglutide, the active ingredient in Wegovy, for the Indian market, even if it requires a clinical trial.
- Biocon aims to introduce generic versions of weight-loss drugs in emerging markets such as Brazil, Mexico, and Saudi Arabia before the patent for semaglutide expires in those countries in 2026.
- The company is striving to obtain a waiver on clinical trials from Indian regulators and submit bioequivalence studies to demonstrate the effectiveness of their version of semaglutide. Biocon is making significant investments in generics research and development, including peptides for weight-loss drugs.
The weight loss drug Ozempic is not linked to suicidal thoughts, regulators say: The European Medicines Agency announced the findings of its nine-month review
qz.com/ema-ozempic-suicidal-thoughts-1851406145
Bullish signal for biotech shares: Will this solve one of Novo Nordisk's biggest problems?
boerse-online.de/nachrichten/aktien/bullisches-signal-fuer-biotech-aktie-loest-das-eines-der-groessten-probleme-von-novo-nordisk-20355342.html
Medicare beneficiaries could be eligible for Wegovy coverage, study shows
reuters.com/business/healthcare-pharmaceuticals/about-36-mln-medicare-beneficiaries-could-be-eligible-wegovy-coverage-study-2024-04-24/
Eli Lilly's weight-loss drug Zepbound might help cure your sleep apnea: Eli Lilly and Company announced promising results for its weight loss drug Zepbound ...
f-st.co/zuvlyJn
EU regulator to review reports of suicidal thoughts and weight loss drugs: A European Medicines Agency committee will this week hold a meeting related to its ...
reuters.com/business/healthcare-pharmaceuticals/eu-health-regulator-discuss-any-link-between-weight-loss-drugs-suicidal-thoughts-2024-04-08/
Novo Nordisk may buy German biotech company Cardior: The German biotech company Cardior is researching an active ingredient against heart failure and is now ...
diepresse.com/18385607/novo-nordisk-darf-deutsche-biotech-firma-cardior-kaufen
Pharmaceutical giant builds new plant: groundbreaking ceremony for Lilly in Alzey
zdf.de/nachrichten/wirtschaft/unternehmen/eli-lilly-alzey-spatenstich-100.html
Novo Nordisk parent refiles US application on Catalent deal: The parent of Wegovy producer Novo Nordisk has refiled an application to the U.S ...
reuters.com/markets/deals/novo-nordisk-parent-refiles-us-application-catalent-deal-2024-04-08/
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
cnbc.com/2024/04/20/weight-loss-drug-patients-spend-less-on-restaurants-takeout-survey.html
Popular weight loss drugs in tight supply as Zepbound shortage could last through June
abcnews.go.com/Health/popular-weight-loss-drugs-tight-supply-zepbound-shortage/story
Hundreds of websites have been hawking fake Ozempic and other weight loss drugs. More may be coming
qz.com/fake-ozempic-websites-shut-down-1851411488
Weight-loss drug startup Metsera wants to take on Novo and Lilly. Here’s what you need to know
fastcompany.com/91110090/metsera-startup-eli-lilly-novo-nordisk-competitor-weight-loss-drugs
Biocon leads India push into weight loss drugs as patents lapse: The Bengaluru-based firm is pivoting to anti-obesity therapies as patents for the blockbuster ...
dailymaverick.co.za/article/2024-04-08-biocon-leads-india-push-into-weight-loss-drugs-as-patents-lapse/
Eli Lilly vs. Novo Nordisk: Is this biotech stock ahead thanks to just one number?
boerse-online.de/nachrichten/aktien/eli-lilly-vs-novo-nordisk-hat-diese-biotech-aktie-dank-nur-einer-zahl-die-nase-vorn-20354696.html
Eli Lilly: billions invested in the pharmaceutical industry: Eli Lilly and other pharmaceutical companies are investing a lot of money in Germany. Why ...
sueddeutsche.de/wirtschaft/medikamente-eli-lilly-wacker-chemie-biontech-investitionen-vfa-deindustrialisierung-1.6531745
Paid articlePaid
Costco enters a controversial industry with its latest move: Costco is expanding one of its beloved programs to include coverage of a growing trend that has ...
thestreet.com/retail/costco-enters-a-controversial-industry-with-its-latest-move
After Boehringer and Lilly, the Chancellor is now also visiting Merck: First Biontech, then Boehringer, Lilly in Alzey, now Merck in Darmstadt and the BKA in ...
allgemeine-zeitung.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/nach-boehringer-und-lilly-besucht-der-kanzler-nun-auch-merck-3514944
Bernie Sanders Is Taking on Ozempic’s ‘Astronomically High’ Price Tag: The Vermont senator is launching an investigation into why these game-changing diabetes ...
gizmodo.com/bernie-sanders-investigation-ozempic-high-cost-1851438517
Novo Reigns, Stellantis Resilient: EMEA Earnings Week Ahead: Novo Nordisk A/S’s reign as Europe’s most valuable company “leaves no room to disappoint” with its ...
bloomberg.com/news/articles/2024-04-26/novo-reigns-stellantis-resilient-emea-earnings-week-ahead
Paid articlePaid
Ozempic ‘oops’ babies spark debate about weight-loss shot use as fertility drugs: A surprising thing is happening to some women on weight-loss drugs who’ve ...
bostonherald.com/2024/04/22/ozempic-oops-babies-spark-debate-about-weight-loss-shot-use-as-fertility-drugs/
Report: 15-year-old is said to have caused a fatal accident in Mainz-Gonsenheim: According to a media report, a 15-year-old is said to have caused the fatal ...
allgemeine-zeitung.de/lokales/mainz/stadt-mainz/bericht-15-jaehriger-soll-toedlichen-unfall-verursacht-haben-3517992
Eli Lilly vs. Johnson & Johnson: Which biotech stock could you get a bargain on now?
boerse-online.de/nachrichten/aktien/eli-lilly-vs-johnson-johnson-bei-welcher-biotech-aktie-koennten-sie-jetzt-ein-super-schnaeppchen-machen-20356132.html
Medicines Agency: No Ozempic pregnancies in the EU: According to the European Medicines Agency, there are no cases of surprise pregnancies caused by Ozempic in ...
profil.at/wissenschaft/arzneimittelagentur-keine-ozempic-schwangerschaften-in-der-eu/402870968
Gilead Q1 Earnings Preview: Most Gains Wiped Out - Cause For Concern?: Gilead Sciences will report its Q1 2024 earnings on Thursday, April 25 ...
seekingalpha.com/article/4685264-gilead-q1-earnings-preview-most-gains-wiped-out-cause-for-concern
Paid articlePaid
Is the weight loss injection expensive hype or the big breakthrough?: We talk to doctor Harald Schneider and F.A.Z. editor Lucia Schmidt about the weight loss ...
faz.net/podcasts/f-a-z-podcast-fuer-deutschland/ist-die-abnehmspritze-teurer-hype-oder-der-grosser-durchbruch-19675445.html
Paid articlePaid
How one state is trying to make weight loss drugs cheaper: Weight loss drugs aren't covered by insurance for North Carolina's state employees ...
nbcnews.com/health/health-news/one-state-trying-make-weight-loss-drugs-cheaper-rcna148997
Location Germany: The Groundbreaking Republic: When companies like Microsoft and Eli Lilly invest in Germany, politicians grab a spade and pat themselves on the ...
zeit.de/wirtschaft/2024-04/standort-deutschland-wirtschaft-investitionen-ausland-microsoft
When Calls the Heart Season 11 Episode 3 Review: Steps Forward: When Calls the Heart Season 11 Episode 3 promised a partnership and further investigation into ...
tvfanatic.com/2024/04/when-calls-the-heart-season-11-episode-3-review-steps-forward/
Run on new weight loss drugs: "Many don't even want their partner to know": Injections from Novo Nordisk and Eli Lilly promise quick slimming on prescription ...
spiegel.de/wirtschaft/unternehmen/wegovy-mounjaro-und-co-kommt-nach-der-abnehmspritze-bald-die-schlankheitspille-a-8d2b1f3f-ec7c-4888-86ae-5494aab96f0e
Zepbound and Mounjaro improve sleep apnea symptoms, Eli Lilly trial shows: A new clinical trial from drugmaker Eli Lilly shows that Zepbound and Mounjaro reduced ...
medicalnewstoday.com/articles/zepbound-mounjaro-improves-sleep-apnea-symptoms
SHAREHOLDER hot stock Gubra: New arrow against pounds in the quiver: Another source of hope in the Danes' pipeline.
deraktionaer.de/artikel/pharma-biotech/aktionaer-hot-stock-gubra-neuer-pfeil-gegen-pfunde-im-koecher-20355945.html
Paid articlePaid
Equity funds: How SAP makes life difficult for fund managers: The rise of megacaps such as Microsoft, Novo Nordisk and SAP is increasingly becoming a problem for ...
capital.de/geld-versicherungen/aktienfonds--wie-sap-fondsmanagern-das-leben-schwer-macht-34650416.html
Paid articlePaid Novo Nordisk Remains The Better Buy After A Moderate Pullback: Novo Nordisk (NVO) continues to be rated as a Buy, with the stock already charting an impressive ...
seekingalpha.com/article/4685043-novo-nordisk-better-buy-after-moderate-pullback
Paid articlePaid
Ozempic's latest reported side effect: pregnancy: A number of women are reporting unplanned pregnancies while taking drugs like Ozempic.
axios.com/2024/04/18/ozempic-pregnancy-weight-loss-drugs-fertility-report
Ozempic Babies: Doctors Want Safety Data on Obesity Shots During Pregnancy: A surprising thing is happening to some women on weight-loss drugs who’ve struggled ...
bloomberg.com/news/articles/2024-04-18/ozempic-babies-doctors-want-safety-data-on-obesity-shots-during-pregnancy
Hanover: Federal Cartel Office approves Cardior takeover: The competition authority has no objections to the new owner Novo Nordisk. The Danes want to buy the ...
neuepresse.de/wirtschaft/regional/hannover-bundeskartellamt-genehmigt-cardior-uebernahme-XW42UM2WENCUFIMJY5IDDCXGEQ.html
Paid articlePaid One time chance? Eli Lilly and Novo Nordisk shares have even more potential than expected
boerse-online.de/nachrichten/aktien/einmalige-chance-die-aktien-von-eli-lilly-und-novo-nordisk-haben-noch-mehr-potenzial-als-gedacht-20355579.html
Top 10 Biggest Companies In The World By Market Cap In 2024 - Forbes India: Curious about the biggest players in the global markets? Explore the top 10 companies ...
forbesindia.com/article/explainers/top-10-largest-companies-world-market-cap/86341/1
Eli Lilly boss: “Patients eat 800 calories less”: The pharmaceutical company Eli Lilly is building a factory in Alzey. Here boss David Ricks talks about a ...
faz.net/aktuell/wirtschaft/eli-lilly-chef-patienten-essen-800-kalorien-weniger-19648578.html
Federal Cartel Office approves purchase of Cardior: Hanover - The Danish pharmaceutical company Novo Nordisk is allowed to buy the biotech company Cardior ...
dlvr.it/T5kfLq
Eight stock picks in AI, obesity drugs and other growth areas beyond the S&P 500: Nicole Kornitzer of Buffalo Funds explains how she invests in ‘secular growth ...
marketwatch.com/story/eight-stock-picks-in-ai-obesity-drugs-e-commerce-and-other-growth-areas-beyond-the-s-p-500-1f84da89
Fake Ozempic sites, more Zepbound shortage, and J&J 's sales miss: Pharma news roundup
qz.com/fake-ozempic-weight-loss-drugs-zepbound-shortage-1851420244
U.S. Stocks Have Outperformed Europe for Years. Why That Could Change for a While.
barrons.com/articles/u-s-stocks-have-outperformed-europe-for-years-why-that-could-change-for-a-while-bf7f2ede
Paid articlePaid
Politicians want to strengthen the pharmaceutical industry - the plan seems to be working
medical-tribune.de/meinung-und-dialog/artikel/pharma-strategen-unter-sich
Boehringer Ingelheim: More than a weight loss injection: In the lucrative diabetes market and obesity medications, preparations with additional benefits for ...
faz.net/aktuell/wirtschaft/unternehmen/wie-boehringer-ingelheim-den-diaetmarkt-aufmischen-koennte-19649868.html
Paid articlePaid Costco enters a controversial industry with its latest move: Costco is expanding one of its beloved programs to include coverage of a growing trend that has ...
thestreet.com/retail/costco-enters-a-controversial-industry-with-its-latest-move
Eli Lilly, Biontech and Co: Where the country should make improvements: Are science and the economy in Rhineland-Palatinate doing well or badly? The members of ...
allgemeine-zeitung.de/politik/politik-rheinland-pfalz/eli-lilly-biontech-und-co-wo-das-land-nachbessern-soll-3491494
Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports: The company reported results of clinical trials involving Zepbound, an obesity drug in the ...
nytimes.com/2024/04/17/health/sleep-apnea-obesity-zepbound.html
Copenhagen's Børsen Tower Can Rise Again With Novo Nordisk's Help: Denmark should take lessons from the fire at Notre Dame — and how French luxury ...
bloomberg.com/opinion/articles/2024-04-16/copenhagen-s-ravaged-stock-exchange-can-rise-again-with-novo-nordisk-help
Paid articlePaid Stigmatization affects the psychology of people with obesity: Every year, Novo Nordisk highlights a special topic from the complex clinical picture of obesity in ...
medical-tribune.de/medizin-und-forschung/artikel/die-unsichtbare-last-des-stigmas
Cardior bosses: “The market for our new drug is huge”: 65 million people worldwide suffer from heart failure. The Hanover company Cardior has developed a new ...
neuepresse.de/wirtschaft/regional/cardior-chefs-der-markt-fuer-unser-neues-medikament-ist-riesig-EQCAWCCSWJDGTOTSVFQV3CIGVA.html
Paid articlePaid
Major investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO
fortune.com/europe/2024/04/10/astrazeneca-boss-pascal-soriot-pay/
Paid articlePaid Obesity-drug power duo Novo Nordisk and Eli Lilly have room to run, analysts say: BMO analysts cut price target for Amgen, another contender in the weight-loss ...
marketwatch.com/story/obesity-drug-power-couple-novo-nordisk-and-eli-lilly-still-have-room-to-run-analysts-say-c37743b9
Huge market: Eli Lilly's slimming syringe - an explosive device for the healthcare system
n-tv.de/wirtschaft/Eli-Lillys-Abnehmspritze-ein-Sprengsatz-fuers-Gesundheitssystem-article24860114.html
Eli Lilly and Company, or Lilly for short, is, among other things, a leading global provider of insulin and other diabetes medications ... Show more
Medical Tribune: Medical Tribune is a medical publisher with information for doctors on diagnosis, therapy and practice management. For over 50 years ...
medical-tribune.de/ddg-akademie-startet-mit-neuem-angebot
Ozempic slimming injection: How pharmaceutical companies play patients off against each other
berliner-zeitung.de/open-source/abnehmspritze-ozempic-wie-pharmakonzerne-patienten-gegeneinander-ausspielen-li.2203936
Costco enters a controversial industry with its latest move: The retail giant is expanding one of its beloved programs to include a growing trend.
charlotteobserver.com/news/business/article287364065.html
Eli Lilly (LLY), Novo (NOVOB DC) Risk Missing High Expectations, Goldman Says: The weight loss drug frenzy that’s driven Eli Lilly & Co. and Novo Nordisk A/S ...
bloomberg.com/news/articles/2024-04-12/lilly-novo-euphoria-risks-disappointing-investors-goldman-says
Paid articlePaid
Bulford girl stars in BBC Newsround for Military Child Month: A GIRL has starred in BBC's Newsround to highlight the unique struggles of life as a military child ...
salisburyjournal.co.uk/news/24247420.bulford-girl-stars-bbc-newsround-military-child-month/
Takeover wave is rolling: Get to know three more hot candidates now: Discover 3 promising radiopharma stocks.
deraktionaer.de/artikel/pharma-biotech/uebernahmewelle-rollt-jetzt-drei-weitere-heisse-kandidaten-kennenlernen-20354959.html
AstraZeneca there: That's why these biotech stocks are now making hearts beat faster on Wall Street
boerse-online.de/nachrichten/aktien/astrazeneca-dabei-darum-lassen-diese-biotech-aktien-an-der-wall-street-jetzt-herzen-hoeher-schlagen--20354827.html
How the 'Oh-Oh-Oh Ozempic' Commercial Song Made a Musician $1 Million: David Paton's 1974 song "Magic" has been repurposed as the theme ...
entrepreneur.com/business-news/ozempic-song-used-in-commercial-makes-70s-rockers-millions/472492
Novo Nordisk: Deal with Ginkgo Bioworks is expanded - the details: The Danes are further expanding their partnership with the synthetic biology specialist.
deraktionaer.de/artikel/pharma-biotech/novo-nordisk-deal-mit-ginkgo-bioworks-wird-erweitert-die-details-20354834.html
Chancellor Scholz visits Alzey: That's what it was like: The Chancellor doesn't come to Alzey every day. Eli Lilly makes it possible. But this requires strict ...
allgemeine-zeitung.de/lokales/alzey/kanzler-scholz-zu-besuch-in-alzey-so-war-das-drumherum-3474791
Wegovy’s heart benefits are not just linked with weight loss, new study suggests: Heart-failure patients with diabetes may shed fewer pounds on Wegovy but still ...
marketwatch.com/story/wegovys-heart-benefits-are-not-just-linked-with-weight-loss-new-study-suggests-1bfcf903
Eli Lilly: Alzey-Dautenheim fears traffic congestion: After the groundbreaking ceremony for the US pharmaceutical company Eli Lilly, Dautenheim's mayor and IG ...
allgemeine-zeitung.de/lokales/alzey/fuer-alzey-dautenheim-bleibt-verkehrsbelastung-der-knackpunkt-3475159
Seaport Therapeutics launches with $100 million to develop new ways to treat mental disorders
bostonglobe.com/2024/04/09/business/seaport-therapeutics-karuna-mental-disorders-medicine/
Meet Europe’s Mag 18. Novo Nordisk Stock, ASML, and Others Can Rival the Mag Seven.
barrons.com/articles/novo-nordisk-asml-lvmh-nestle-european-mag-stocks-554d95c7
Paid articlePaid Novo Nordisk: The Moat Won't Last Forever: Novo Nordisk is currently the preeminent player in this burgeoning GLP-1 market space. Click here to read an analysis ...
seekingalpha.com/article/4682909-novo-nordisk-the-moat-wont-last-forever
Paid articlePaid Eli Lilly's weight loss injection: explosive device for the German health system: Eli Lilly, the largest pharmaceutical company in the world, will soon be ...
capital.de/wirtschaft-politik/eli-lillys-abnehmspritze--sprengsatz-fuers-deutsche-gesundheitssystem-34607690.html
I Invested in Ozempic—It Taught Me a Valuable Lesson: It is now more valuable than Tesla.
newsweek.com/i-invested-ozempic-it-taught-me-valuable-lesson-1887867
Drugmaker seeks approval for China's first biosimilar Ozempic: A drugmaker in China has developed a biosimilar version of Novo Nordisk's popular diabetes drug ...
reuters.com/business/healthcare-pharmaceuticals/chinas-first-biosimilar-ozempic-drug-applies-approval-2024-04-03/
Why A Pullback Is Bullish For IBD Stock Of The Day Novo Nordisk: Novo Nordisk is Friday's IBD Stock Of The Day. After hitting a record high in March ...
investors.com/research/ibd-stock-of-the-day/novo-nordisk-stock-pullback-weight-loss-drugs/
Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
cnbc.com/2024/04/04/danone-ceo-downplays-threat-of-weight-loss-drugs-on-food-producers.html
Next
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics